keyword
MENU ▼
Read by QxMD icon Read
search

Boron neutron capture therapy

keyword
https://www.readbyqxmd.com/read/28103709/radiation-absorbed-dose-estimates-for-18f-bpa-pet
#1
Yuzuru Kono, Hiroaki Kurihara, Hiroshi Kawamoto, Naoko Yasui, Naoki Honda, Hiroshi Igaki, Jun Itami
Background Boron neutron capture therapy (BNCT) is a molecular radiation therapy approach based on the (10)B (n, α) (7)Li nuclear reaction in cancer cells. In BNCT, delivery of (10)B in the form of 4-borono-phenylalanine conjugated with fructose (BPA-fr) to the cancer cells is important. The PET tracer 4-borono-2-18F-fluoro-phenylalanine (FBPA) has been used to predict the accumulation of BPA-fr before BNCT. Purpose To determine the biodistribution and dosimetric parameters in 18F-BPA PET/CT studies. Material and Methods Human biokinetic data were obtained during clinical 18F-BPA PET studies between February and June 2015 at one institution...
January 1, 2017: Acta Radiologica
https://www.readbyqxmd.com/read/28088230/relationship-between-the-uptake-of-18-f-borono-l-phenylalanine-and-l-methyl-11-c-methionine-in-head-and-neck-tumors-and-normal-organs
#2
Yoshiaki Watanabe, Hiroaki Kurihara, Jun Itami, Ryohei Sasaki, Yasuaki Arai, Kazuro Sugimura
BACKGROUND AND PURPOSE: The purpose of this study was to determine the distribution of 4-borono-2-(18)F-fluoro-phenylalanine ((18)F-BPA) and L-[methyl-(11)C] methionine ((11)C-Met) in normal organs and tumors and to evaluate the usefulness of (11)C-Met/PET in screening potential candidates for boron neutron capture therapy (BNCT). MATERIAL METHODS: Seven patients who had at least one histologically confirmed head and neck tumor were included in this study. They underwent both whole-body (18)F-BPA-PET/CT and (11)C-Met-PET/CT within a span of 6 months...
January 14, 2017: Radiation Oncology
https://www.readbyqxmd.com/read/28049613/a-13-c-d-n-based-epithermal-neutron-source-for-boron-neutron-capture-therapy
#3
M E Capoulat, A J Kreiner
PURPOSE: Boron Neutron Capture Therapy (BNCT) requires neutron sources suitable for in-hospital siting. Low-energy particle accelerators working in conjunction with a neutron producing reaction are the most appropriate choice for this purpose. One of the possible nuclear reactions is (13)C(d,n)(14)N. The aim of this work is to evaluate the therapeutic capabilities of the neutron beam produced by this reaction, through a 30mA beam of deuterons of 1.45MeV. METHODS: A Beam Shaping Assembly design was computationally optimized...
December 31, 2016: Physica Medica: PM
https://www.readbyqxmd.com/read/28046629/tu-fg-brb-07-gpu-based-prompt-gamma-ray-imaging-from-boron-neutron-capture-therapy
#4
S Kim, T Suh, D Yoon, J Jung, H Shin, M Kim
PURPOSE: The purpose of this research is to perform the fast reconstruction of a prompt gamma ray image using a graphics processing unit (GPU) computation from boron neutron capture therapy (BNCT) simulations. METHODS: To evaluate the accuracy of the reconstructed image, a phantom including four boron uptake regions (BURs) was used in the simulation. After the Monte Carlo simulation of the BNCT, the modified ordered subset expectation maximization reconstruction algorithm using the GPU computation was used to reconstruct the images with fewer projections...
June 2016: Medical Physics
https://www.readbyqxmd.com/read/28046581/su-f-t-183-design-of-a-beam-shaping-assembly-of-a-compact-dd-based-boron-neutron-capture-therapy-system
#5
M Hsieh, Y Liu, L Nie
PURPOSE: To design a beam shaping assembly (BSA) to shape the 2.45-MeV neutrons produced by a deuterium-deuterium (DD) neutron generator and to optimize the beam output for boron neutron capture therapy of brain tumors METHODS: MCNP is used for this simulation study. The simulation model consists of a neutron surface source that resembles an actual DD source and is surrounded by a BSA. The neutron source emits 2.45-MeV neutrons isotropically. The BSA is composed of a moderator, reflector, collimator and filter...
June 2016: Medical Physics
https://www.readbyqxmd.com/read/28039054/intracellular-delivery-and-passive-tumor-targeting-of-a-self-assembled-nanogel-containing-carborane-clusters-for-boron-neutron-capture-therapy
#6
Riku Kawasaki, Yoshihiro Sasaki, Kazunari Akiyoshi
Boron neutron capture therapy, based on the release of thermal neutron irradiation from boron, is a targeted radiation therapy for cancer. Targeted and sufficient accumulation of boron in tumor cells to achieve cytotoxic efficacy and reduce off-target effects remains a challenge. Carborane has been investigated for use as a delivery agent in boron neutron capture therapy because of its high boron content and chemical stability; however, it is cytotoxic, making safe delivery difficult. The aim of this study was to investigate the potential of carborane-bearing pullulan nanogels to safely and effectively deliver boron to tumor cells in vitro and in vivo and, consequently, assess their potential as a boron neutron capture therapeutic...
December 27, 2016: Biochemical and Biophysical Research Communications
https://www.readbyqxmd.com/read/27889131/development-of-monte-carlo-based-real-time-treatment-planning-system-with-fast-calculation-algorithm-for-boron-neutron-capture-therapy
#7
Kenta Takada, Hiroaki Kumada, Peng Hong Liem, Hideyuki Sakurai, Takeji Sakae
PURPOSE: We simulated the effect of patient displacement on organ doses in boron neutron capture therapy (BNCT). In addition, we developed a faster calculation algorithm (NCT high-speed) to simulate irradiation more efficiently. METHODS: We simulated dose evaluation for the standard irradiation position (reference position) using a head phantom. Cases were assumed where the patient body is shifted in lateral directions compared to the reference position, as well as in the direction away from the irradiation aperture...
December 2016: Physica Medica: PM
https://www.readbyqxmd.com/read/27824199/lipid-membrane-incorporated-arylboronate-esters-as-agents-for-boron-neutron-capture-therapy
#8
Masafumi Ueda, Kengo Ashizawa, Kouta Sugikawa, Kazuya Koumoto, Takeshi Nagasaki, Atsushi Ikeda
Arylboronate esters bearing methyl groups in both of their ortho positions were stably incorporated into lipid membranes at high concentrations without undergoing hydrolysis to the corresponding boronic acids. This method could be used in combination with previous methods to increase the maximum ratio of boron atoms in liposomal boron carriers.
November 8, 2016: Organic & Biomolecular Chemistry
https://www.readbyqxmd.com/read/27821116/comparison-of-the-pharmacokinetics-between-l-bpa-and-l-fbpa-using-the-same-administration-dose-and-protocol-a-validation-study-for-the-theranostic-approach-using-18-f-l-fbpa-positron-emission-tomography-in-boron-neutron-capture-therapy
#9
Tsubasa Watanabe, Yoshihide Hattori, Youichiro Ohta, Miki Ishimura, Yosuke Nakagawa, Yu Sanada, Hiroki Tanaka, Satoshi Fukutani, Shin-Ichiro Masunaga, Masahiro Hiraoka, Koji Ono, Minoru Suzuki, Mitsunori Kirihata
BACKGROUND: Boron neutron capture therapy (BNCT) is a cellular-level particle radiation therapy that combines the selective delivery of boron compounds to tumour tissue with neutron irradiation. L-p-Boronophenylalanine (L-BPA) is a boron compound now widely used in clinical situations. Determination of the boron distribution is required for successful BNCT prior to neutron irradiation. Thus, positron emission tomography with [(18)F]-L-FBPA, an (18)F-labelled radiopharmaceutical analogue of L-BPA, was developed...
November 8, 2016: BMC Cancer
https://www.readbyqxmd.com/read/27806584/triple-ionization-chamber-method-for-clinical-dose-monitoring-with-a-be-covered-li-bnct-field
#10
Thanh Tat Nguyen, Tsuyoshi Kajimoto, Kenichi Tanaka, Chien Cong Nguyen, Satoru Endo
PURPOSE: Fast neutron, gamma-ray, and boron doses have different relative biological effectiveness (RBE). In boron neutron capture therapy (BNCT), the clinical dose is the total of these dose components multiplied by their RBE. Clinical dose monitoring is necessary for quality assurance of the irradiation profile; therefore, the fast neutron, gamma-ray, and boron doses should be separately monitored. To estimate these doses separately, and to monitor the boron dose without monitoring the thermal neutron fluence, the authors propose a triple ionization chamber method using graphite-walled carbon dioxide gas (C-CO2), tissue-equivalent plastic-walled tissue-equivalent gas (TE-TE), and boron-loaded tissue-equivalent plastic-walled tissue-equivalent gas [TE(B)-TE] chambers...
November 2016: Medical Physics
https://www.readbyqxmd.com/read/27759052/nanostructured-boron-nitride-with-high-water-dispersibility-for-boron-neutron-capture-therapy
#11
Bikramjeet Singh, Gurpreet Kaur, Paviter Singh, Kulwinder Singh, Baban Kumar, Ankush Vij, Manjeet Kumar, Rajni Bala, Ramovatar Meena, Ajay Singh, Anup Thakur, Akshay Kumar
Highly water dispersible boron based compounds are innovative and advanced materials which can be used in Boron Neutron Capture Therapy for cancer treatment (BNCT). Present study deals with the synthesis of highly water dispersible nanostructured Boron Nitride (BN). Unique and relatively low temperature synthesis route is the soul of present study. The morphological examinations (Scanning/transmission electron microscopy) of synthesized nanostructures showed that they are in transient phase from two dimensional hexagonal sheets to nanotubes...
October 19, 2016: Scientific Reports
https://www.readbyqxmd.com/read/27757932/comparison-of-the-image-derived-radioactivity-and-blood-sample-radioactivity-for-estimating-the-clinical-indicators-of-the-efficacy-of-boron-neutron-capture-therapy-bnct-4-borono-2-18-f-fluoro-phenylalanine-fbpa-pet-study
#12
Kayako Isohashi, Eku Shimosegawa, Sadahiro Naka, Yasukazu Kanai, Genki Horitsugi, Ikuko Mochida, Keiko Matsunaga, Tadashi Watabe, Hiroki Kato, Mitsuaki Tatsumi, Jun Hatazawa
BACKGROUND: In boron neutron capture therapy (BNCT), positron emission tomography (PET) with 4-borono-2-(18)F-fluoro-phenylalanine (FBPA) is the only method to estimate an accumulation of (10)B to target tumor and surrounding normal tissue after administering (10)B carrier of L-paraboronophenylalanine and to search the indication of BNCT for individual patient. Absolute concentration of (10)B in tumor has been estimated by multiplying (10)B concentration in blood during BNCT by tumor to blood radioactivity (T/B) ratio derived from FBPA PET...
December 2016: EJNMMI Research
https://www.readbyqxmd.com/read/27674552/a-dose-response-analysis-of-head-and-neck-cancer-patients-treated-with-boron-neutron-capture-therapy-bnct
#13
H Koivunoro, L Kankaanranta, H T Joensuu
No abstract text is available yet for this article.
October 1, 2016: International Journal of Radiation Oncology, Biology, Physics
https://www.readbyqxmd.com/read/27640175/design-of-thermal-neutron-beam-based-on-an-electron-linear-accelerator-for-bnct
#14
Mona Zolfaghari, Mahmood Sedaghatizadeh
An electron linear accelerator (Linac) can be used for boron neutron capture therapy (BNCT) by producing thermal neutron flux. In this study, we used a Varian 2300 C/D Linac and MCNPX.2.6.0 code to simulate an electron-photoneutron source for use in BNCT. In order to decelerate the produced fast neutrons from the photoneutron source, which optimize the thermal neutron flux, a beam-shaping assembly (BSA) was simulated. After simulations, a thermal neutron flux with sharp peak at the beam exit was obtained in the order of 3...
December 2016: Applied Radiation and Isotopes
https://www.readbyqxmd.com/read/27608327/dendrimers-as-innovative-radiopharmaceuticals-in-cancer-radionanotherapy
#15
Flonja Liko, François Hindré, Eduardo Fernandez-Megia
Radiotherapy is one of the most commonly used cancer treatments, with an estimate of 40% success that could be improved further if more efficient targeting and retention of radiation at the tumor site were achieved. This review focuses on the use of dendrimers in radionanotherapy, an emerging technology aimed to improve the efficiency of radiotherapy by implementing nanovectorization, an already established praxis in drug delivery and diagnosis. The labeling of dendrimers with radionuclides also aims to reduce the dose of radiolabeled materials and, hence, their toxicity and tumor resistance...
October 10, 2016: Biomacromolecules
https://www.readbyqxmd.com/read/27586407/assessment-of-10-b-concentration-in-boron-neutron-capture-therapy-potential-of-image-guided-therapy-using-18-fbpa-pet
#16
Eku Shimosegawa, Kayako Isohashi, Sadahiro Naka, Genki Horitsugi, Jun Hatazawa
OBJECTIVES: In boron neutron capture therapy (BNCT) for cancer, the accurate estimation of (10)B tissue concentrations, especially in neighboring normal organs, is important to avoid adverse effects. The (10)B concentration in normal organs after loading with (10)B, however, has not been established in humans. In this study, we performed 4-borono-2-[(18)F]-fluoro-phenylalanine ((18)FBPA) PET in healthy volunteers and estimated the chronological changes in the (10)B concentrations of normal organs...
December 2016: Annals of Nuclear Medicine
https://www.readbyqxmd.com/read/27573907/measurements-of-the-thermal-neutron-flux-for-an-accelerator-based-photoneutron-source
#17
Ali Taheri, Ali Pazirandeh
To have access to an appropriate neutron source is one of the most demanding requirements for neutron studies. This is important specially in laboratory and clinical applications, which need more compact and accessible sources. The most known neutron sources are fission reactors and natural isotopes, but there is an increasing interest for using accelerator based neutron sources because of their advantages. In this paper, we shall present a photo-neutron source prototype which is designed and fabricated to be used for different neutron researches including in-laboratory neutron activation analysis and neutron imaging, and also preliminary studies in boron neutron capture therapy (BNCT)...
August 29, 2016: Australasian Physical & Engineering Sciences in Medicine
https://www.readbyqxmd.com/read/27568399/boron-neutron-capture-synovectomy-bncs-as-a-potential-therapy-for-rheumatoid-arthritis-radiobiological-studies-at-ra-1-nuclear-reactor-in-a-model-of-antigen-induced-arthritis-in-rabbits
#18
Verónica A Trivillin, Leandro J Bruno, David A Gatti, Mariela Stur, Marcela A Garabalino, Andrea Monti Hughes, Jorge Castillo, Emiliano C C Pozzi, Luis Wentzeis, Hugo Scolari, Amanda E Schwint, Sara Feldman
Rheumatoid arthritis is a chronic autoimmune pathology characterized by the proliferation and inflammation of the synovium. Boron neutron capture synovectomy (BNCS), a binary treatment modality that combines the preferential incorporation of boron carriers to target tissue and neutron irradiation, was proposed to treat the pathological synovium in arthritis. In a previous biodistribution study, we showed the incorporation of therapeutically useful boron concentrations to the pathological synovium in a model of antigen-induced arthritis (AIA) in rabbits, employing two boron compounds approved for their use in humans, i...
August 27, 2016: Radiation and Environmental Biophysics
https://www.readbyqxmd.com/read/27548011/amphiphilic-polycarbonates-from-carborane-installed-cyclic-carbonates-as-potential-agents-for-boron-neutron-capture-therapy
#19
Hejian Xiong, Xing Wei, Dongfang Zhou, Yanxin Qi, Zhigang Xie, Xuesi Chen, Xiabin Jing, Yubin Huang
Carboranes with rich boron content have showed significant applications in the field of boron neutron capture therapy. Biodegradable derivatives of carborane-conjugated polymers with well-defined structure and tunable loading of boron atoms are far less explored. Herein, a new family of amphiphilic carborane-conjugated polycarbonates was synthesized by ring-opening polymerization of a carborane-installed cyclic carbonate monomer. Catalyzed by TBD from a poly(ethylene glycol) macroinitiator, the polymerization proceeded to relatively high conversions (>65%), with low polydispersity in a certain range of molecular weight...
September 21, 2016: Bioconjugate Chemistry
https://www.readbyqxmd.com/read/27516940/preparation-and-characterization-of-10-b-boric-acid-with-high-purity-for-nuclear-industry
#20
Weijiang Zhang, Tianyu Liu, Jiao Xu
Boric acid is often added into coolant as neutron capture agent for pressurized water reactor, whose amount is influenced by its abundance and purity. Therefore, the preparation of enriched (10)B boric acid with high purity is beneficial to nuclear industry. (10)B is also used in developing tumor-specific boronated drugs in boron neutron capture therapy. The boronated drug can be administered to patient intravenously, intratumorally, or deposited at tumor site in surgical excision. Thus, enriched (10)B boric acid is of practical significance in the field of medicine...
2016: SpringerPlus
keyword
keyword
57541
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"